Skip to main content
Nevada Public Radio
  • News 88.9 KNPR
  • Classical 89.7 kcnv
  • Magazine Desert Companion
  • About

    How to reach us

    1289 S. Torrey Pines Dr.
    Las Vegas, NV 89146

    Main Number:  1-702-258-9895
    Toll Free: 1-888-258-9895

    More contact info

     

     

      • Staff
      • Board of Directors
      • Employment
      • CPB Compliance
      • Our Policies
      • Listen on the Radio
      • Other Ways to Listen
      • Sign-up for NVPR News
      • FCC Public Inspection File
      • CPB Funding
      • History
    • News 88.9 KNPR
    • Classical 89.7 KCNV
    • Desert Companion
  • Programs

    On News 88.9 KNPR

    On Classical 89.7

    News

    • All Things Considered
    • BBC World Service
    • Here & Now
    • Hidden Brain
    • It's Been a Minute with Sam Sanders
    • KNPR's State of Nevada
    • Marketplace
    • Morning Edition
    • On Point
    • On the Media
    • Planet Money - How I Built This
    • Reveal
    • The Daily
    • The Takeaway
    • Weekend Edition Saturday
    • Weekend Edition Sunday

    Humor

    • Ask Me Another
    • Live Wire!
    • Wait Wait...Don't Tell Me!

    Arts & Life

    • Bullseye
    • Desert Bloom
    • Fresh Air
    • Nevada Yesterdays
    • Radiolab
    • Snap Judgment
    • Sound Opinions
    • TED Radio Hour
    • The Business
    • The Moth
    • This American Life

    Classical

    • Chicago Symphony Orchestra
    • Classical Music
    • Concierto
    • From the Top
    • Music from the Hearts of Space
    • New York Philharmonic
    • Performance Today
    • Pipedreams
    • Pittsburgh Symphony Orchestra
    • Sunday Baroque
    • SymphonyCast

    Special Projects

    • Race and Racism in Nevada
    • StoryCorps Virtual: Las Vegas
    • Coronavirus - What You Need to Know
    • Fifth Street
  • Projects
  • Support
      • Support NVPR
      • Contact Member Services
      • Corporate Support
      • Donate your Car
      • Give Voice Major Gift Initiative
      • myPublicRadio
  • myPublicRadio
  • Donate Now
      • Member Benefits
      • Planned Giving
      • Volunteer

Main menu

Search

Listen

News 88.9 KNPR
Classical 89.7 KCNV
Podcasts view all

member station

Support
Subscribe to coronavirus vaccine trials

coronavirus vaccine trials

NPR
Shots - Health News
According to a review published in 2018, nearly 75% of the drugs approved by the Food and Drug Administration in the 21st century had no data associated with their use during pregnancy.
Tweet Share on Facebook Share on Google+ Email

Protect Pregnant Women 'Through Research,' Not 'From Research,' OB-GYNs Urge

Jan 25, 2021
As COVID-19 vaccines roll out, doctors say it's long past time to address the exclusion of pregnant women from research on drugs and vaccines. They say better study design is the answer.
NPR
Shots - Health News
News of a good immune response in animals bodes well for testing future COVID-19 vaccines.
Tweet Share on Facebook Share on Google+ Email

Immune Response In Animals Good News For COVID-19 Vaccine Development

Dec 04, 2020
Researchers found that a class of antibodies in a monkey's blood provides protection from COVID-19. If that hold true for humans, a blood test may predict whether a vaccine candidate is working.
NPR
Coronavirus Updates
AstraZeneca, along with Oxford University, announced early Monday its vaccine trial was shown to be "highly effective" in preventing COVID-19.
Tweet Share on Facebook Share on Google+ Email

AstraZeneca Trial Promises 'Highly Effective' COVID-19 Vaccine

Nov 23, 2020

The pharmaceutical company made the announcement on Monday, saying that one dosing regimen showed the vaccine was 90% effective in preventing infection.

NPR
Investigations
Albert Bourla, chairman and CEO of Pfizer, sold millions of dollars' worth of company stock on Monday as part of a preset plan. But NPR found irregularities about when the CEO entered into that plan.
Tweet Share on Facebook Share on Google+ Email

Pfizer CEO Sold Millions In Stock After Coronavirus Vaccine News, Raising Questions

Nov 11, 2020
Pfizer's CEO sold $5.6 million worth of stock on Monday. The company says the stock sale was made as part of a preset plan. But NPR found irregularities about when the CEO entered into that plan.
  • Listen Download
NPR
Coronavirus Live Updates
The study is still awaiting final regulatory approval. If given the green light, a study in which human volunteers will be infected with the coronavirus will begin in January at a biosecure unit at London's Royal Free Hospital.
Tweet Share on Facebook Share on Google+ Email

U.K. Preparing COVID-19 Vaccine Trials That Deliberately Expose Study Subjects

Oct 20, 2020
Proponents say that such controversial "human challenge" studies can speed up vaccine development. But others cite ethical concerns.
NPR
Shots - Health News
Tweet Share on Facebook Share on Google+ Email

As COVID-19 Vaccine Trials Move At Warp Speed, Recruiting Black Volunteers Takes Time

Sep 11, 2020
Some pharmaceutical companies are well into the final phase of clinical trials for a coronavirus vaccine. But efforts to recruit patients from minority groups are just beginning.
  • home
  • How to reach us
  • About
  • Support
  • Twitter
  • Facebook
  • NVPR News
  • Instagram

© All Rights Reserved. | Privacy Policy

PRXNPRAPMBBC INN